Iti Pharma And Healthcare Fund Datagrid
Category Sectoral/ Thematic
BMSMONEY Rank 4
Rating
Growth Option 30-09-2026
NAV ₹17.66(R) -2.31% ₹19.46(D) -2.31%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 11.85% 16.76% -% -% -%
Direct 13.88% 18.96% -% -% -%
Benchmark
SIP (XIRR) Regular 17.44% 10.9% -% -% -%
Direct 19.52% 12.98% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.77 0.39 0.74 4.84% 0.15
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
16.66% -23.79% -16.32% 0.9 12.11%
Fund AUM As on: 30/12/2025 230 Cr
Top Sectoral/ Thematic
Fund Name Rank Rating
HDFC Defence Fund 1
Aditya Birla Sun Life Special Opportunities Fund 2
Franklin India Opportunities Fund 3
ITI Pharma and Healthcare Fund 4
SBI Comma Fund 5

NAV Date: 30-09-2026

Scheme Name NAV Rupee Change Percent Change
ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option 17.66
-0.4200
-2.3100%
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 17.66
-0.4200
-2.3100%
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option 19.46
-0.4600
-2.3100%
ITI Pharma and Healthcare Fund - Direct Plan - IDCW Option 19.46
-0.4600
-2.3100%

Review Date: 30-09-2026

Beginning of Analysis

ITI Pharma and Healthcare Fund is the 12th ranked fund in the Sectoral/ Thematic Fund category. The category has total 22 funds. The ITI Pharma and Healthcare Fund has shown an average past performence in Sectoral/ Thematic Fund. The fund has a Jensen Alpha of 4.84% which is higher than the category average of 2.23%. Here the fund has shown very good performance in terms of risk adjusted returns. The fund has a Sharpe Ratio of 0.77 which is higher than the category average of 0.53.
The past performance of the fund may or may not be sustained in the future. The review is not investment advice nor is it a recommendation to buy or sell funds. The ranking is based on proprietary methodology developed by bmsmoney. The methodology is based on the past performance of the funds and does not guarantee future performance.
Sectoral/Thematic Mutual Funds are ideal for aggressive investors seeking high returns by investing in a specific sector or theme. These funds offer targeted exposure to sectors like banking, technology, or themes like infrastructure and ESG, allowing investors to capitalize on the growth potential of these segments. However, they carry higher risks due to their concentrated exposure and are heavily dependent on the performance of the chosen sector or theme. Investors should have a long-term investment horizon, a high risk tolerance, and a good understanding of the sector or theme before investing in these funds. Additionally, timing the market and monitoring sectoral trends are crucial for success.

ITI Pharma and Healthcare Fund Return Analysis

The ITI Pharma and Healthcare Fund has delivered a mixed performance across various time horizons, showcasing both strengths and challenges when compared to its Sectoral/ Thematic Fund peers and the Nifty 500 TRI benchmark. This analysis examines the fund’s returns over periods ranging from one month to ten years, alongside its Systematic Investment Plan (SIP) performance, highlighting its rankings within the Sectoral/ Thematic Fund category and its ability to outperform or underperform the benchmark and category averages.

  • The fund has given a return of -4.05%, 2.29 and 20.96 in last one, three and six months respectively. In the same period the category average return was -4.78%, -0.77% and 14.44% respectively.
  • ITI Pharma and Healthcare Fund has given a return of 13.88% in last one year. In the same period the Nifty 500 TRI return was -2.0%. The fund has given 15.88% more return than the benchmark return.
  • The fund has given a return of 18.96% in last three years and rank 3rd out of twenty five funds in the category. In the same period the Nifty 500 TRI return was 9.99%. The fund has given 8.97% more return than the benchmark return.
  • The fund has given a SIP return of 19.52% in last one year whereas category average SIP return is 5.95%. The fund one year return rank in the category is 12th in 49 funds
  • The fund has SIP return of 12.98% in last three years and ranks 5th in 24 funds. HDFC Defence Fund has given the highest SIP return (26.9%) in the category in last three years.

ITI Pharma and Healthcare Fund Risk Analysis

  • The fund has a standard deviation of 16.66 and semi deviation of 12.11. The category average standard deviation is 16.47 and semi deviation is 11.99.
  • The fund has a Value at Risk (VaR) of -23.79 and a maximum drawdown of -16.32. The category average VaR is -23.88 and the maximum drawdown is -19.09. The fund has a beta of 0.87 which shows that fund is less volatile than the benchmark.

Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.


  • Very Good Performance in Sectoral/ Thematic Fund Category
  • Good Performance in Sectoral/ Thematic Fund Category
  • Poor Performance in Sectoral/ Thematic Fund Category
  • Very Poor Performance in Sectoral/ Thematic Fund Category

    • Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

    Data Source: www.amfiindia.com

    SEBI Categorization


    KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -4.19 -5.85
    -4.84
    		-8.00 | 0.77 17 | 59 Good
    3M Return % 1.85 -3.73
    -0.93
    		-7.55 | 9.50 14 | 57 Very Good
    6M Return % 19.92 8.21
    14.06
    		-3.64 | 37.42 15 | 57 Very Good
    1Y Return % 11.85 -2.03
    4.83
    		-8.78 | 29.05 13 | 49 Very Good
    3Y Return % 16.76 9.52
    12.08
    		2.52 | 35.44 5 | 25 Very Good
    1Y SIP Return % 17.44
    5.43
    		-16.72 | 35.15 13 | 46 Good
    3Y SIP Return % 10.90
    5.65
    		-5.02 | 25.59 5 | 23 Very Good
    Standard Deviation 16.66
    16.47
    		13.04 | 31.30 16 | 24 Average
    Semi Deviation 12.11
    11.99
    		9.67 | 21.32 18 | 24 Average
    Max Drawdown % -16.32
    -19.09
    		-31.05 | -12.71 6 | 24 Very Good
    VaR 1 Y % -23.79
    -23.88
    		-36.55 | -16.03 12 | 24 Good
    Average Drawdown % 7.62
    8.10
    		5.67 | 15.72 12 | 24 Good
    Sharpe Ratio 0.77
    0.53
    		-0.07 | 1.12 5 | 24 Very Good
    Sterling Ratio 0.74
    0.54
    		0.14 | 1.04 5 | 24 Very Good
    Sortino Ratio 0.39
    0.27
    		0.00 | 0.63 4 | 24 Very Good
    Jensen Alpha % 4.84
    2.23
    		-6.89 | 17.71 6 | 24 Very Good
    Treynor Ratio 0.15
    0.10
    		-0.01 | 0.23 3 | 24 Very Good
    Modigliani Square Measure % 11.88
    8.19
    		-1.04 | 17.20 5 | 24 Very Good
    Alpha % 3.95
    2.38
    		-8.72 | 26.46 8 | 24 Good
    Return data last Updated On : Sept. 30, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
    KPIs: Key Performance Indicators

    Rotate the phone! Best viewed in landscape mode on mobile.
    KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -4.05 -5.85 -4.78 -7.88 | 0.85 17 | 61 Good
    3M Return % 2.29 -3.73 -0.77 -7.19 | 9.73 14 | 59 Very Good
    6M Return % 20.96 8.21 14.44 -2.88 | 38.28 15 | 59 Very Good
    1Y Return % 13.88 -2.03 5.78 -8.22 | 29.18 13 | 50 Very Good
    3Y Return % 18.96 9.52 13.34 3.80 | 36.91 3 | 25 Very Good
    1Y SIP Return % 19.52 5.95 -15.38 | 36.83 12 | 49 Very Good
    3Y SIP Return % 12.98 6.73 -3.81 | 26.90 5 | 24 Very Good
    Standard Deviation 16.66 16.47 13.04 | 31.30 16 | 24 Average
    Semi Deviation 12.11 11.99 9.67 | 21.32 18 | 24 Average
    Max Drawdown % -16.32 -19.09 -31.05 | -12.71 6 | 24 Very Good
    VaR 1 Y % -23.79 -23.88 -36.55 | -16.03 12 | 24 Good
    Average Drawdown % 7.62 8.10 5.67 | 15.72 12 | 24 Good
    Sharpe Ratio 0.77 0.53 -0.07 | 1.12 5 | 24 Very Good
    Sterling Ratio 0.74 0.54 0.14 | 1.04 5 | 24 Very Good
    Sortino Ratio 0.39 0.27 0.00 | 0.63 4 | 24 Very Good
    Jensen Alpha % 4.84 2.23 -6.89 | 17.71 6 | 24 Very Good
    Treynor Ratio 0.15 0.10 -0.01 | 0.23 3 | 24 Very Good
    Modigliani Square Measure % 11.88 8.19 -1.04 | 17.20 5 | 24 Very Good
    Alpha % 3.95 2.38 -8.72 | 26.46 8 | 24 Good
    Return data last Updated On : Sept. 30, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
    KPIs: Key Performance Indicators

    Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


    Date Iti Pharma And Healthcare Fund NAV Regular Growth Iti Pharma And Healthcare Fund NAV Direct Growth
    30-09-2026 17.6626 19.4628
    29-09-2026 18.0807 19.9225
    28-09-2026 18.0503 19.8882
    25-09-2026 18.2447 20.0995
    24-09-2026 18.3102 20.1707
    23-09-2026 18.4454 20.3188
    22-09-2026 18.2936 20.1506
    21-09-2026 18.4005 20.2674
    18-09-2026 18.2069 20.0514
    17-09-2026 18.0364 19.8626
    16-09-2026 17.7783 19.5775
    15-09-2026 17.8053 19.6063
    11-09-2026 18.0725 19.8969
    10-09-2026 18.1286 19.9577
    09-09-2026 18.2127 20.0493
    08-09-2026 18.2591 20.0994
    07-09-2026 18.1098 19.9341
    04-09-2026 18.039 19.8534
    03-09-2026 18.1512 19.976
    02-09-2026 18.1854 20.0127
    01-09-2026 18.2022 20.0303
    31-08-2026 18.4347 20.2852

    Fund Launch Date: 17/Nov/2021
    Fund Category: Sectoral/ Thematic
    Investment Objective: The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
    Fund Description: An open ended equity scheme investing in Pharma and Healthcare
    Fund Benchmark: Nifty Healthcare Total Return Index
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.